[Efficacy and safety analysis of BTK inhibitors combined with R-CHOP regimen in newly diagnosed double-expressor diffuse large B-cell lymphoma].

J B Lu、L Cao、H L Liu、Y Miao、H R Shen、Y Xia、H Yin、Y X Cheng

2026PubMed被引 1开放获取

摘要

BTKi combined with R-CHOP significantly improved response rates and survival in patients with DE-DLBCL, with manageable safety.

引用本文（GB/T 7714）

J B Lu, L Cao, H L Liu, 等. [Efficacy and safety analysis of BTK inhibitors combined with R-CHOP regimen in newly diagnosed double-expressor diffuse large B-cell lymphoma].[J]. PubMed, 2026.

引文网络

参考文献与被引分析加载中…

DOI：https://doi.org/10.3760/cma.j.cn121090-20250811-00375

本站仅收录题录与摘要供学习参考，全文版权归属出版方；如有侵权请联系我们删除。